Gestational diabetes: screening for all, which test and which treatment?

Area of Science:

• Obstetrics and Gynecology
• Endocrinology
• Public Health

Background:

• Rising incidence of gestational diabetes mellitus (GDM) linked to lifestyle, obesity, and maternal age.
• Current screening practices for GDM are not universal, despite increasing prevalence.
• Uncertainty exists regarding optimal diagnostic criteria and risk stratification for GDM.

Purpose of the Study:

• To discuss and debate current controversies in gestational diabetes mellitus management.
• To explore differing perspectives on screening, diagnosis, and treatment of GDM.
• To address the safety and efficacy of oral antidiabetic agents in GDM.

Main Methods:

• Discussion and debate during the Controversies in Obstetrics, Gynecology and Infertility annual meetings.
• Review of current literature and clinical guidelines on GDM screening and treatment.
• Analysis of differing viewpoints on diagnostic cutoff values and pharmacological interventions.

Main Results:

• No consensus was reached on universal screening mandates for GDM.
• Debate continues on whether to use strict or liberal oral glucose tolerance test (OGTT) cutoff values.
• The safety and role of oral antidiabetic drugs (glyburide, metformin) versus insulin in GDM remain contentious.

Conclusions:

• Significant disagreements persist regarding the optimal approach to GDM screening and diagnosis.
• The use of oral antidiabetic medications in GDM requires further investigation and consensus.
• Addressing GDM controversies is crucial for improving maternal and offspring outcomes.